First AD

Second AD

Lung Cancer

JAN-22-OSD1275 - /clinical/lung-cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Head & Neck Cancers

The OncLive Head and Neck Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with head and neck cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research within head and neck cancer. 

The Future of RET Inhibitors in Non-Small Cell Lung and Thyroid Cancer 

Insights

Notable RET Inhibitor Trials Underway

Why RET Alteration is an Attractive Target for Therapy

RET Fusion, Point Mutation, and Signaling

Multikinase TKIs for NSCLC and Medullary Thyroid Cancer

RET Treatment: Novel Compounds to Replace Current TKIs

The Importance of NGS Testing

RET Testing in Papillary and Medullary Thyroid Cancer

LIBRETTO-001 Regimen Overview

LOXO-292 in Patients With RET-Fusion Lung Cancer

ESMO 2019 LIBRETTO-001 Trial Updates

How BLU-667 Has Changed the Treatment Landscape

RET Inhibitor Trial Updates at ASCO and ESMO

Using RET Inhibitors in Clinical Practice

The Next Steps in RET Inhibitor Research